After OA-induced hepatic steatosis, we evaluated the expression of PPARγ and its downstream genes, including genes involved in lipid transport, synthesis, and β-oxidation, following treatment with celastrol, rosiglitazone, or GW9662. Here, PPARG is linked to fatty liver disease.